Deoxycytidine kinase
From Proteopedia
(Difference between revisions)
| Line 16: | Line 16: | ||
</StructureSection> | </StructureSection> | ||
| - | == 3D Structures of deoxycytidine kinase == | ||
| - | Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}} | ||
| - | {{#tree:id=OrganizedByTopic|openlevels=0| | ||
| - | |||
| - | *dCK complex with chemotherapy agent | ||
| - | |||
| - | **[[1p5z]], [[1p62]], [[2a7q]] – hDCK + ADP + chemotherapy agent – human<br /> | ||
| - | **[[2no9]], [[2noa]], [[2no0]], [[2no6]], [[2zi9]] – hDCK (mutant) + ADP + chemotherapy agent <br /> | ||
| - | **[[2zia]], [[4kcg]] – hDCK (mutant) + UDP + chemotherapy agent <br /> | ||
| - | **[[5mqi]], [[5mqt]], [[5mql]] – hDCK (mutant) + UDP + dCMP + chemotherapy agent<br /> | ||
| - | |||
| - | *dCK complex with nucleoside | ||
| - | |||
| - | **[[1p60]], [[1p61]], [[3kfx]] – hDCK + ADP + dC<br /> | ||
| - | **[[2no1]], [[2no7]] – hDCK (mutant) + ADP + dC<br /> | ||
| - | **[[2zi3]], [[2zi4]] – hDCK (mutant) + ADP + dA<br /> | ||
| - | **[[3hp1]] – hDCK (mutant) + ADP + dT<br /> | ||
| - | **[[2zi5]], [[2zi6]] – hDCK (mutant) + UDP + dA<br /> | ||
| - | **[[2zi7]] – hDCK (mutant) + UDP + dG<br /> | ||
| - | **[[2a2z]], [[3qen]] – hDCK (mutant) + UDP + dC<br /> | ||
| - | **[[3qeo]] – hDCK (mutant) + UDP + dT<br /> | ||
| - | **[[2a30]] – hDCK (mutant) + dC<br /> | ||
| - | **[[5mqj]] – hDCK (mutant) + UDP + UMP<br /> | ||
| - | |||
| - | *Other dCK complexes | ||
| - | |||
| - | **[[2qrn]] – hDCK + UDP + CMP<br /> | ||
| - | **[[2qro]] – hDCK + UDP + AMP<br /> | ||
| - | **[[3ipx]] – hDCK + ADP + inhibitor<br /> | ||
| - | **[[3ipy]] – hDCK + inhibitor<br /> | ||
| - | **[[3qej]] – hDCK (mutant) + UDP <br /> | ||
| - | **[[4jlj]], [[4jlk]], [[4jlm]], [[4jln]], [[4l5b]], [[4q18]], [[4q19]], [[4q1a]], [[4q1b]], [[4q1c]], [[4q1d]], [[4q1e]], [[4q1f]] - hDCK (mutant) + UDP + inhibitor<br /> | ||
| - | **[[3mjr]] – hDCK + UDP + hydroxyethoxymethylguanine<br /> | ||
| - | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 08:44, 5 June 2019
| |||||||||||
References
- ↑ Hazra S, Ort S, Konrad M, Lavie A. Structural and kinetic characterization of human deoxycytidine kinase variants able to phosphorylate 5-substituted deoxycytidine and thymidine analogues . Biochemistry. 2010 Aug 10;49(31):6784-90. PMID:20614893 doi:10.1021/bi100839e
- ↑ Sabini E, Ort S, Monnerjahn C, Konrad M, Lavie A. Structure of human dCK suggests strategies to improve anticancer and antiviral therapy. Nat Struct Biol. 2003 Jul;10(7):513-9. PMID:12808445 doi:http://dx.doi.org/10.1038/nsb942
